Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Experientia
|
October 15, 1976
Lipoperoxidation rates and drug-oxidizing enzyme activities in the liver and placenta of some mammal species during the perinatal period
P Arvela, N T Kärki, R O Pelkonen
European Journal of Clinical Pharmacology
|
April 1, 1980
Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays
E A Sotaniemi, R O Pelkonen, M Puukka
Diabetes
|
October 1, 1980
The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus
P I Salmela, E A Sotaniemi, R O Pelkonen
Lancet (London, England)
|
January 7, 1984
Alcohol, HDL cholesterol, and liver microsomal induction
P V Luoma, E A Sotaniemi, R O Pelkonen
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1983
Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man
P V Luoma, E A Sotaniemi, R O Pelkonen
European Journal of Clinical Pharmacology
|
January 1, 1982
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
H I Pirttiaho, E A Sotaniemi, R O Pelkonen, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1980
Treatment of alcoholic cirrhosis with enzyme inducers
A Rautio, E A Sotaniemi, R O Pelkonen, et al.
Research Communications in Chemical Pathology and Pharmacology
|
July 1, 1982
High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
April 1, 1980
Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Experientia
|
October 15, 1976
Lipoperoxidation rates and drug-oxidizing enzyme activities in the liver and placenta of some mammal species during the perinatal period
P Arvela, N T Kärki, R O Pelkonen
European Journal of Clinical Pharmacology
|
April 1, 1980
Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays
E A Sotaniemi, R O Pelkonen, M Puukka
Diabetes
|
October 1, 1980
The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus
P I Salmela, E A Sotaniemi, R O Pelkonen
Lancet (London, England)
|
January 7, 1984
Alcohol, HDL cholesterol, and liver microsomal induction
P V Luoma, E A Sotaniemi, R O Pelkonen
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1983
Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man
P V Luoma, E A Sotaniemi, R O Pelkonen
European Journal of Clinical Pharmacology
|
January 1, 1982
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
H I Pirttiaho, E A Sotaniemi, R O Pelkonen, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1980
Treatment of alcoholic cirrhosis with enzyme inducers
A Rautio, E A Sotaniemi, R O Pelkonen, et al.
Research Communications in Chemical Pathology and Pharmacology
|
July 1, 1982
High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
April 1, 1980
Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
Page
of 3